Aplastic anemia: the role of immunosuppression.
In a young, previously untransfused patient for whom a compatible donor can be found, marrow transplantation may be optimal. Otherwise, immunosuppression provides an effective therapeutic alternative.
Billett
H H
HH
Department of Pathology, Long Island Jewish Medical Center, New Hyde Park, N.Y.
D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001856:Bone Marrow Examination; D016026:Bone Marrow Transplantation / Q000592:standards; D003663:Decision Trees; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards; D009504:Neutrophils; D010976:Platelet Count
D000961:Antilymphocyte Serum